Magnesium Glycinate is a longevity product whose active basis is enzymatic cofactor (300+ reactions). Lowers blood pressure, supports many enzymes. It is positioned for resale to the growing healthspan-focused consumer market.
Modest BP reduction lowers cardiovascular risk. Research relevant to this mechanism is indexed on PubMed and linked below; it describes the mechanism rather than this specific product.
Peer-reviewed studies on the active compound — citations link to PubMed.
“magnesium significantly reduced systolic and diastolic blood pressure”
“Magnesium intake resulted in a reduction in systolic blood pressure”
“significant reduction of systolic and diastolic blood pressure in T2DM patients”
“This systematic review provides Grade C (possibly effective) evidence for prevention of migraine with magnesium.”
“Intravenous magnesium reduces acute migraine attacks within 15 - 45 minutes, 120 minutes, and 24 hours after the initial infusion and oral magnesium alleviates the frequency and intensity of migraine.”
Research describes the active mechanism and is not a claim about this specific product.
Slightly reduces coronary mortality and events. Research relevant to this mechanism is…
Counters sarcopenia, frailty and bone loss in aging. Research relevant to this mechanism…
Counters oxidative stress accumulating with age. Research relevant to this mechanism is…
Maintains immune competence across the lifespan. Research relevant to this mechanism is…
Yes — its active compound is linked to 5 peer-reviewed studies, summarized and cited above.
You can buy it on Amazon via the link above; Magellan earns a small affiliate commission at no extra cost to you, which does not affect the evidence grade.
Dietary supplements and devices are generally well tolerated but are not a substitute for medical care. Talk to your physician before starting, especially if you take medication or have a health condition.